July 1993
Volume 34, Issue 8
Free
Articles  |   July 1993
Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Author Affiliations
  • M Nishi
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • C P Herbort
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • M Matsubara
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • Y Morishita
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • M Nishimura
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • M Nieda
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • S Mori
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
  • M Mochizuki
    Department of Ophthalmology, Escola Paulista de Medicina, São Paulo, Brazil.
Investigative Ophthalmology & Visual Science July 1993, Vol.34, 2477-2486. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Nishi, C P Herbort, M Matsubara, Y Morishita, M Nishimura, M Nieda, S Mori, M Mochizuki; Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.. Invest. Ophthalmol. Vis. Sci. 1993;34(8):2477-2486.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: The immunosuppressive effects of FK506 on allogeneic corneal transplantation were tested in a rat model. METHODS: Inbred-strain Lewis rats were used as recipients, and Fisher rats were used as donors. Intraperitoneal injection of FK506 (0.3, 1.0, and 3.0 mg/kg per day) was administered for 2 weeks, and the grafts were inspected by clinical evaluation. Mixed lymphocyte culture assay, using lymphocytes from recipients of penetrating keratoplasty as responder cells and irradiated splenocytes from naive Fisher or Brown Norway as stimulator cells, was used to identify allogeneic stimulation. The rejection process was studied by histology and immunohistochemistry. RESULTS: The rat strain combination developed 100% graft rejection in about 2 weeks after the penetrating keratoplasty. FK506 prolonged the graft survival in a dose-dependent manner, as observed by clinical evaluation. In mixed lymphocyte culture assay, Lewis rats that had been primed to allogeneic stimulation at the time of cornea transplantation presented significant proliferation to Fisher stimulator splenocytes. FK506 suppressed this primed lymphocyte proliferation. Immunohistochemical and histologic studies confirmed the clinical evaluations. Untreated rat corneas, at the second postoperative week, presented a large number of helper/inducer T cells, macrophages, IL-2 receptor-expressing cells, and Ia-antigen-expressing cells. In the same period, FK506-treated rats appeared normal and had no cellular infiltration. Corneas rejected after FK506 cessation had less intense cell infiltration than the control corneas. CONCLUSIONS: These data indicate that FK506 prolonged the corneal graft survival and can be a potentially useful drug in the immunotherapeutic arsenal to suppress corneal graft rejection.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×